CEO Joseph Jimenez of Swiss drugmaker Novartis addresses the company's annual news conference in Basel January 29, 2014. Swiss drugmaker Novartis reduced this year's sales forecasts on Wednesday, ... more 
CEO Joseph Jimenez of Swiss drugmaker Novartis addresses the company's annual news conference in Basel January 29, 2014. Swiss drugmaker Novartis reduced this year's sales forecasts on Wednesday, signalling it expected delayed generic competition to its once best-selling blood pressure pill Diovan in the second quarter. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS DRUGS SOCIETY HEALTH) less 
1 / 27
Reuters | Photo By ARND WIEGMANN / REUTERS
Wed, Jan 29, 2014 5:10 AM EST